Investors & Media

Ionis announces new chief global product strategy officer to lead next phase of commercial growth

Kyle Jenne  rejoins company to lead commercial strategy Onaiza Cadoret-Manier departing for new career opportunity With broad commercial capabilities in place, Ionis ready to execute on its first independent launches CARLSBAD, Calif. , Feb. 29, 2024 /PRNewswire/ —  Ionis Pharmaceuticals , Inc. 

Read more
You are now leaving https://www.ionispharma.com to visit